• Atherogenic Markers In Predicting Cardiovascular Risk And Targeting Residual Cardiovascular Risk 

      Catapano, A.L.; Tokgözoğlu, L.; Mello e Silva, A.; Bruckert, E. (2019)
      Low-density lipoprotein (LDL)cholesterol (LDL-C)is the primary target in cardiovascular (CV)disease prevention and is commonly used in estimating CV risk; however, alternative markers may be needed when LDL-C is not an ...
    • Impact Of Diabetes Mellitus And Chronic Kidney Disease On Cardiovascular Outcomes And Platelet P2Y(12) Receptor Antagonist Effects In Patients With Acute Coronary Syndromes: Insights From The Plato Trial 

      Franchi, Francesco; James, Stefan K.; Lakic, Tatevik Ghukasyan; Budaj, Andrzej J.; Cornel, Jan H.; Katus, Hugo A.; Keltai, Matyas; Kontny, Frederic; Lewis, Basil S.; Storey, Robert F.; Himmelmann, Anders; Wallentin, Lars; Angiolillo, Dominick J.; Parkhomenko, Alexander Nikolaevich; Oto, Ali; Skene, Allan; Budaj, Andrzej; Freij, Anneli; Santoso, Anwar; Armando; Lewis, Basil S.; Meier, Bernhard; Yu, Cheuk Man; Cannon, Christopher P.; Zambahari, Dato Seri Robaayah; Wu, Delon Wu; Ardissino, Diego; Raev, Dimitar; Kremastinos, Dimitrios; Weaver, Douglas; Paolasso, Ernesto; Giannitsis, Evangelos; Kontny, Frederic; Verheugt, Freek; Maurer, Gerald; Katus, Hugo; Emanuelsson, Hakan; Cornel, Jan H.; Horrow, Jay; Bassand, Jean-Pierre; Spinar, Jindrich; Morais, Joao; Lopez Sendon, Jose; Nicolau, Jose; Seung, Ki-Bae; Wallentin, Lars; Teik, Lim Soo; Heras, Magda; Claeys, Marc J.; Sabatine, Marc; Vintila, Marius; Keltai, Matyas; Ruda, Mikhail; Thorsen, Mona; Kleiman, Neil; Babilonia, Noe; Commerford, Patrick; Gurbel, Paul; Aylward, Phil; Steg, Philippe Gabriel; Theroux, Pierre; Sritara, Piyamitr; Pais, Prem; Becker, Richard; Lassila, Riitta; Harrington, Robert A.; Storey, Robert F.; Gao, Runlin; Husted, Steen; James, Stefan K.; Duris, Tibor; Chapichadze, Zaza; Investigators, PLATO (2019)
      Background-There are limited data on how the combination of diabetes mellitus (DM) and chronic kidney disease (CKD) affects cardiovascular outcomes as well as response to different P2Y(12) receptor antagonists, which ...